Clinical Trial Update: Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating thyroxine treatment for intraventricular hemorrhage of prematurity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraventricular Hemorrhage of Prematurity

Drugs mentioned

• thyroxine (thyroxine)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Intraventricular Hemorrhage of Prematurity | Phase 3 | Status: WITHDRAWN